6-Nitro-1H-indole-2-carboxylic acid, 97%, 1g

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole, 97%, 5g

2-(2-Formylaminothiazol-4-yl)acetic acid, 95.0%, 25g

2-Pyrimidinamine, 4-(3,4-dihydro-1-methyl-2(1H)-isoquinolinyl)-N-(4-fluorophenyl)-5,6-dimethyl-, hydrochloride (1:1), 5g

4-Naphthalen-1-ylaniline, 97%, 25g

(4-Aminotetrahydro-2H-pyran-3-yl)methanol, 98+%, 250mg

ROTI®Cell 10x DPBS, 1 l

5-Cyclobutyl-4H-1,2,4-triazol-3-ylamine, 95.0%, 5g

1-(2,6-Dichloro-3-nitrophenyl)ethanone, 95%, 250mg

BENZYL (3R,4R)-4-AMINO-3-FLUOROPIPERIDINE-1-CARBOXYLATE, 95.0%, 250mg

2-methyl-1-propyl-1H-benzimidazol-5-amine dihydrochloride, 95.0%, 10g

6-Methylbenzofuran-2-carboxylic acid, 98+%, 1g

4-Methyl-7-nitroindoline, 95.0%, 50mg